86 related articles for article (PubMed ID: 11916008)
1. Functional polymorphism in the promoter region of the gelatinase B gene in relation to coronary artery disease and restenosis after percutaneous coronary intervention.
Cho HJ; Chae IH; Park KW; Ju JR; Oh S; Lee MM; Park YB
J Hum Genet; 2002; 47(2):88-91. PubMed ID: 11916008
[TBL] [Abstract][Full Text] [Related]
2. Polymorphism in the gelatinase B gene and the severity of coronary arterial stenosis.
Wang J; Warzecha D; Wilcken D; Wang XL
Clin Sci (Lond); 2001 Jul; 101(1):87-92. PubMed ID: 11410119
[TBL] [Abstract][Full Text] [Related]
3. Genetic diversity of RANTES gene promoter and susceptibility to coronary artery disease and restenosis after percutaneous coronary intervention.
Vogiatzi K; Voudris V; Apostolakis S; Kochiadakis GE; Thomopoulou S; Zaravinos A; Spandidos DA
Thromb Res; 2009 May; 124(1):84-9. PubMed ID: 19201454
[TBL] [Abstract][Full Text] [Related]
4. Gelatinase B C(-1562)T polymorphism in relation to ischaemic heart disease.
Haberbosch W; Gardemann A
Scand J Clin Lab Invest; 2005; 65(6):513-22. PubMed ID: 16179285
[TBL] [Abstract][Full Text] [Related]
5. The 5A6A polymorphism in the promoter of the stromelysin-1 (MMP3) gene as a risk factor for restenosis.
Humphries S; Bauters C; Meirhaeghe A; Luong L; Bertrand M; Amouyel P
Eur Heart J; 2002 May; 23(9):721-5. PubMed ID: 11977998
[TBL] [Abstract][Full Text] [Related]
6. The 5A/6A polymorphism of the stromelysin-1 gene and restenosis after percutaneous coronary interventions.
Hoppmann P; Koch W; Schömig A; Kastrati A
Eur Heart J; 2004 Feb; 25(4):335-41. PubMed ID: 14984923
[TBL] [Abstract][Full Text] [Related]
7. p27kip1-838C>A single nucleotide polymorphism is associated with restenosis risk after coronary stenting and modulates p27kip1 promoter activity.
van Tiel CM; Bonta PI; Rittersma SZ; Beijk MA; Bradley EJ; Klous AM; Koch KT; Baas F; Jukema JW; Pons D; Sampietro ML; Pannekoek H; de Winter RJ; de Vries CJ
Circulation; 2009 Aug; 120(8):669-76. PubMed ID: 19667240
[TBL] [Abstract][Full Text] [Related]
8. Inflammation and apoptosis genes and the risk of restenosis after percutaneous coronary intervention.
Monraats PS; de Vries F; de Jong LW; Pons D; Sewgobind VD; Zwinderman AH; de Maat MP; 't Hart LM; Doevendans PA; de Winter RJ; Tio RA; Waltenberger J; Frants RR; van der Laarse A; van der Wall EE; Wouter Jukema J
Pharmacogenet Genomics; 2006 Oct; 16(10):747-54. PubMed ID: 17001294
[TBL] [Abstract][Full Text] [Related]
9. Lipoprotein lipase gene polymorphisms and the risk of target vessel revascularization after percutaneous coronary intervention.
Monraats PS; Rana JS; Nierman MC; Pires NM; Zwinderman AH; Kastelein JJ; Kuivenhoven JA; de Maat MP; Rittersma SZ; Schepers A; Doevendans PA; de Winter RJ; Tio RA; Frants RR; Quax PH; van der Laarse A; van der Wall EE; Jukema JW
J Am Coll Cardiol; 2005 Sep; 46(6):1093-100. PubMed ID: 16168296
[TBL] [Abstract][Full Text] [Related]
10. Relationship of interleukin-6-572C/G promoter polymorphism and serum levels to post-percutaneous coronary intervention restenosis.
Gao J; Liu Y; Cui RZ; Mao YM; Zhou J; Chen Q; Zhao FM; Yang GM
Chin Med J (Engl); 2013 Mar; 126(6):1019-25. PubMed ID: 23506572
[TBL] [Abstract][Full Text] [Related]
11. The roles of stromelysin-1 and the gelatinase B gene polymorphism in stable angina.
Kim JS; Park HY; Kwon JH; Im EK; Choi DH; Jang YS; Cho SY
Yonsei Med J; 2002 Aug; 43(4):473-81. PubMed ID: 12205736
[TBL] [Abstract][Full Text] [Related]
12. Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease.
Blankenberg S; Rupprecht HJ; Poirier O; Bickel C; Smieja M; Hafner G; Meyer J; Cambien F; Tiret L;
Circulation; 2003 Apr; 107(12):1579-85. PubMed ID: 12668489
[TBL] [Abstract][Full Text] [Related]
13. Interleukin 10: a new risk marker for the development of restenosis after percutaneous coronary intervention.
Monraats PS; Kurreeman FA; Pons D; Sewgobind VD; de Vries FR; Zwinderman AH; de Maat MP; Doevendans PA; de Winter RJ; Tio RA; Waltenberger J; Huizinga TW; Eefting D; Quax PH; Frants RR; van der Laarse A; van der Wall EE; Jukema JW
Genes Immun; 2007 Jan; 8(1):44-50. PubMed ID: 17122782
[TBL] [Abstract][Full Text] [Related]
14. Role of the CD14 C(-260)T promoter polymorphism in determining the first clinical manifestation of coronary artery disease.
Rizzello V; Liuzzo G; Trabetti E; Di Giannuario G; Brugaletta S; Santamaria M; Piro M; Boccanelli A; Pignatti PF; Biasucci LM; Crea F
J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):20-5. PubMed ID: 19829130
[TBL] [Abstract][Full Text] [Related]
15. No association between the C-1562T polymorphism in the promoter of matrix metalloproteinase-9 gene and non-small cell lung carcinoma.
Wang Y; Fang S; Wei L; Wang R; Jin X; Wen D; Li Y; Guo W; Wang N; Zhang J
Lung Cancer; 2005 Aug; 49(2):155-61. PubMed ID: 15949868
[TBL] [Abstract][Full Text] [Related]
16. The influence of established genetic variation in the haemostatic system on clinical restenosis after percutaneous coronary interventions.
Pons D; Monraats PS; de Maat MP; Pires NM; Quax PH; van Vlijmen BJ; Rosendaal FR; Zwinderman AH; Doevendans PA; Waltenberger J; de Winter RJ; Tio RA; Frants RR; van der Laarse A; van der Wall EE; Jukema JW
Thromb Haemost; 2007 Dec; 98(6):1323-8. PubMed ID: 18064331
[TBL] [Abstract][Full Text] [Related]
17. Influence of the CD14 C260T promoter polymorphism on C-reactive protein levels in patients with coronary artery disease.
Bernardo E; Angiolillo DJ; Ramírez C; Cavallari U; Trabetti E; Sabaté M; Hernández R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Costa MA; Bass TA; Pignatti PF; Macaya C; Fernandez-Ortiz A
Am J Cardiol; 2006 Nov; 98(9):1182-4. PubMed ID: 17056323
[TBL] [Abstract][Full Text] [Related]
18. No association found between the insertion/deletion of a 287-bp alu repeat sequence within intron 16 of the angiotensin-I-converting enzyme (ACE) gene in Mexican patients and binary restenosis after coronary stenting.
Martínez-Ríos MA; Peña-Duque MA; Fragoso JM; Delgadillo-Rodríguez H; Pérez-Hernández N; Miranda-Malpica E; Rodríguez-Pérez JM; González-Quesada C; Vargas-Alarcón G
Clin Chim Acta; 2008 Nov; 397(1-2):65-7. PubMed ID: 18706898
[TBL] [Abstract][Full Text] [Related]
19. Homocysteine status and polymorphisms of methylenetetrahydrofolate reductase are not associated with restenosis after stenting in coronary arteries.
Koch W; Ndrepepa G; Mehilli J; Braun S; Burghartz M; Lengnick H; Kölling K; Schömig A; Kastrati A
Arterioscler Thromb Vasc Biol; 2003 Dec; 23(12):2229-34. PubMed ID: 14604831
[TBL] [Abstract][Full Text] [Related]
20. Candidate genetic markers and the risk of restenosis after coronary angioplasty.
Völzke H; Grimm R; Robinson DM; Wolff B; Schwahn C; Hertwig S; Motz W; Rettig R
Clin Sci (Lond); 2004 Jan; 106(1):35-42. PubMed ID: 12899665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
